Aduhelm’s loudest physician proponents have taken money from Biogen

Aduhelm's loudest physician proponents have taken money from Biogen

WASHINGTON — A small group of physicians with deep, at times undisclosed, financial ties to the drug maker Biogen has emerged as the most vocal defenders of the company’s questionably effective and costly Alzheimer’s drug, Aduhelm. The four doctors, who all served as consultants to Biogen in 2020, have written articles in scientific journals defending … Read more